How will the coronavirus pandemic impact psychiatry as a field? Are there any neuropsychiatric symptoms associated with the COVID-19 virus? Those questions answered in this video.
John J. Miller, MD
What do we tell patients regarding the pandemic both in terms of office policies and preparations for self-isolation and quarantine as well as dealing with uncertainty?
It can be disheartening to hear about the pervasive culture at many medical centers and health care systems to ostracize the pharmaceutical industry, and not uncommonly, to threaten to fire employed physicians and clinicians who would like to attend educational programs about new medications on their own free time.
As we navigate uncharted waters on the pandemic front, John J. Miller, MD, shares his thought about this important topic and what he is doing differently both professionally and personally.
Experts discuss the rationale and history of L-methylfolate use in patients, and then shares three cases that collectively suggest L-methylfolate may contribute to agitation and mania.
When we meet a new patient who presents with "classic" symptoms, there are challenges described in this brief video.
Editor in Chief John Miller, MD, shares his insights on the upcoming Psychiatric Times World CME Conference in October.
Here we are—beginning a new day and a new decade—and, once again, we are filled with excitement, hope, anxiety, and fear.
Medicine and psychology have integrated the basic principles of mindfulness into many diverse treatment modalities. Seven are listed here.
In our role as clinicians, we participate in the practice of medicine because there is always more to learn, and more experience to be gained. Such is the case with mindfulness...